Jsmc-10269

PREVALENCE OF LATENT MYCOBACTERIUM TUBERCULOSIS INFECTIONS AMONG DIABETIC PATIENTS ATTENDING SHILAN PRIVATE HOSPITAL, DUHOK CITY

Ahmed Mohammed Salih a

a Duhok Medical Research Center, University of Duhok, Kurdistan Region, Iraq.

Submitted: 1/1/2019; Accepted: 1/12/2020; Published: 21/12/2020

DOI Link: https://doi.org/10.17656/jsmc.10269

ABSTRACT

Background

One-third of the world’s population is estimated to have latent tuberculosis infection. There is a well-documented association between diabetes and active tuberculosis, but evidence of the association between diabetes combined with other factors and latent tuberculosis infection remains limited and inconsistent.

Objectives

The study aimed at evaluating the association between diabetes linked to other risk factors with the latent tuberculosis infection.

Patients and Methods

In the present cross-sectional study, 385 diabetic patients were enrolled between the period of May 2016 and May 2017 at Shilan private hospital labs- Duhok city. Of these, 282 patients accepted to participate. The delayed-type hypersensitivity reaction to Mycobacterium tuberculosis was evaluated by the tuberculin skin test (TST). This test involved the intradermal injection of 5 tuberculin units per test dose of 0.1 mL of purified protein derivative (Mantoux). Out of the 282 patients, 205 patients completed the TST evaluation and 77 patients did not.

Results

Of the 205 diabetes mellitus patients completed the study, 33 (16.1%) patients showed latent tuberculosis infection, and 2 (0.9%) patients had active tuberculosis (TB) (one pulmonary TB and one TB lymphadenitis). As a result, 203 diabetic patients were included in this study. The majorities of the patients were older than 50 years (66.50%) and they were females (69.95%). Diabetic patients with latent tuberculosis infection were significantly associated with injectable or combination antidiabetic therapy, and also with smoking. No significant association with other variables was found.

Conclusion

The presence of diabetes mellitus did not significantly affect the rate of latent tuberculosis infection on its own. However, when diabetes mellitus was linked with injectable, combined antidiabetic, or smoking, the rate of latent tuberculosis infection has shown to be significantly increased.

KEYWORDS

LTBI; Diabetes mellitus; TST.

References

1. Pablos-Mendez A, Blustein J, Knirsch CA. The role of diabetes mellitus in the higher prevalence of tuberculosis among Hispanics. Am J Public Health. 1997;12(4):574–579.

2. Laura Munoz, Helen R. Stagg, Ibrahim Abubakar. Diagnosis and management of Latent Tuberculosis Infection. Cold Spring Harb Perspect Med. 2015;5(11)

3. Mansilla Bermejo MJ, Sanz Gil MJ, Moraleda Velasco P, Alvarez Prado A, Carbayo Garcia JJ, Mata Guijarro F. Tuberculin test in diabetic patients in a health center. Aten Primaria. 1995;12(3):154–157.

4. Vega Torres RA, Conde JG, Diaz M. Prevalence of tuberculin reactivity and risk factors for the development of active tuberculosis upon admission to a nursing home. P R Health Sci J. 1996;12(4):275–277.

5. Nwabudike LC, Ionescu-Tirgoviste C. Intradermal reactions to purified protein derivative in patients with diabetes mellitus. Rom J Intern Med. 2005;12(1-2):127–132.

6. Hernandez Garcia P, Martinez Cruz F, Cayuelas Martinez T. PPD and chemoprophylaxis in diabetes mellitus. Aten Primaria. 1992;12(2):106–108.

7. Brock I, Ruhwald M, Lundgren B, Westh H, Mathiesen LR, Ravn P. Latent tuberculosis in HIV positive, diagnosed by the M. tuberculosis-specific interferon-gamma test. Respir Res. 2006;1;7:56.

8. Chan-Yeung M, Cheung AH, Dai DL, Chan FH, Kam KM, Tam CM, et al. Prevalence and determinants of positive tuberculin reactions of residents in old age homes in Hong Kong. Int J Tuberc Lung Dis. 2006;12(8):892–898.

9. Kim HA, Yoo CD, Baek HJ, Lee EB, Ahn C, Han JS, Kim S, Lee JS, Choe KW, Song YW. Mycobacterium tuberculosis infection in a corticosteroid-treated rheumatic disease patient population. Clin Exp Rheumatol 1998;16(1):9–13

10. Leung CC, Lam TH, Chan WM, Yew WW, Ho KS, Leung GM, Law WS, Tam CM, Chan CK, Chang KC. Diabetic control and risk of tuberculosis: a cohort study. Am J Epidemiol 2008;167(12):1486–94.

11. Young F, Wotton CJ, Critchley JA, Unwin NC, Goldacre MJ. Increased risk of tuberculosis disease in people with diabetes mellitus: a record-linkage study in a UK population. J Epidemiol Community Health. 2012;66(6):519-23.

12. Jeon CY, Murray MB. Diabetes mellitus increases the risk of active tuberculosis: a systematic review of 13 observational studies. PLoS Med. 2008; 15;5(7):e152.

13. Chen CH, Lian JD, Cheng CH, Wu MJ, Lee WC, Shu KH. Mycobacterium tuberculosis infection following renal transplantation in Taiwan. Transpl Infect Dis 2006;8(3):148–56

14. John GT, Shankar V, Abraham AM, Mukundan U, Thomas PP, Jacob CK. Risk factors for post-transplant tuberculosis. Kidney Int. 2001;60 (3):1148–53.

15. Kim SJ, Hong YP, Lew WJ, Yang SC, Lee EG. Incidence of pulmonary tuberculosis among diabetics. Tuber Lung Dis.1995;76 (6):529–33.

16. American Diabetes Association. Classification and diagnosis of diabetes, Sec. 2: In Standards of Medical Care in Diabetes, 2017. Diabetes Care. 2017; 40(Suppl. 1):11–24.

17. CDC. Guidelines for preventing the transmission of Mycobacterium tuberculosis in health-care settings, 2005. MMWR. 2005; 54(17):1-141.

18. Arnedo-Pena A, Juan-Cerdán JV, Romeu-García MA, García-Ferrer D2, Holguín-Gómez R3, Iborra-Millet J2, Pardo-Serrano F. Vitamin D status and incidence of tuberculosis infection conversion in contacts of pulmonary tuberculosis patients: a prospective cohort study. Epidemiol Infect. 2015; 143(8):1731–41.

19. Dobler CC, Flack JR, Marks GB. Risk of tuberculosis among people with diabetes mellitus: an Australian nationwide cohort study. BMJ Open. 2012; 2(1).

20. Swarna Nantha Y, Puri A, Mohamad Ali SZ, Suppiah P, Che Ali SA, Ramasamy B, Ibrahim IM. Epidemiology of latent tuberculosis infection among patients with and without diabetes mellitus. Fam Pract. 2017; 1;34(5):532–538.

21. Lee MR, Huang YP, Kuo YT, Luo CH, Shih YJ, Shu CC, et al. Diabetes mellitus and latent tuberculosis infection: a systemic review and meta-analysis. Clin Infect Dis. 2016.

22. Al-Rifai RH, Pearson F, Critchley JA, Abu-Raddad LJ. Association between diabetes mellitus and active tuberculosis: A systematic review and meta-analysis. PLoS One.2017.

23. Leung CC, Lam TH, Chan WM, Wing W. Yew, Kin S. Ho, Gabriel M. Leung, Wing S. Law, Cheuk M. Tam, Chi K. Chan, Kwok C. Chang. Diabetic control and risk of tuberculosis: a cohort study. Am J Epidemiol. 2008;167(15):1486e94.

24. den Boon S, van Lill SWP, Borgdorff M, Verver S, Bateman ED, Lombard CJ, Enarson DA, Beyers N. Association between smoking and tuberculosis infection: a population survey in a high tuberculosis incidence area. Thorax. 2005; 60(7): 555–557.

25. Horne DJ, Campo M, Ortiz JR, Oren E, Arentz M, Crothers K, Narita M. Association between smoking and latent tuberculosis in the U.S. population: an analysis of the National Health and Nutrition Examination Survey. PLoS One. 2012; 7 (11):e49050.

26. Jia-Yih F, Shiang-Fen H, Wen-Ying T, Ming-Che L, Yu-Chun C, Yung-Yang L, Yu-Chin Lee, Wei-Juin Su.Impact of cigarette smoking on latent tuberculosis infection: does age matter?. Eur Respir J. 2014; 43: 630–632.

27. Horne DJ, Campo M, Ortiz JR, Oren E, Arentz M, Crothers K, et al. Association between Smoking and Latent Tuberculosis in the U.S. Population: An Analysis of the National Health and Nutrition Examination Survey. PloS One. 2012;(11)7.

28. Oni T, Gideon HP, Bangani N, Relebohile Tsekela, Ronnett Seldon, Kathryn Wood, Katalin A. Wilkinson, Rene T. Goliath, Tom H. M. Ottenhoff, and Robert J. Wilkinson. Smoking, BCG, and employment and the risk of tuberculosis infection in HIV infected persons in South Africa. PLoS One. 2012; 7 (10): e47072.

29. Aabye MG, Hermansen TS, Ruhwald M, George PrayGod, Daniel Faurholt-Jepsen, Kidola Jeremiah, Maria Faurholt- Jepsen, Nyagosya Range, Henrik Friis, John Changalucha, Aase B Andersen Pernille Ravn. A negative effect of smoking on the performance of the QuantiFERON TB Gold in-tube test. BMC Infect Dis. 2012; 12: 379.

30. Kim SJ, Hong YP, Lew WJ, Yang SC, Lee EG. Incidence of pulmonary tuberculosis among diabetics. Tuber Lung Dis 1995; 76(6):529-33.

31. Ponce-De-Leon A, Garcia-Garcia Md Mde L, Garcia-Sancho MC, Gomez-Perez FJ, Valdespino-Gomez JL, Olaiz-Fernandez G, Rojas R, Ferreyra-Reyes L, Cano-Arellano B, Bobadilla M, Small PM, Sifuentes-Osornio J. Tuberculosis and diabetes in southern Mexico. Diabetes Care 2004; 27(7): 1584-90.

32. Dyck RF, Klomp H, Marciniuk DD, Tan L, Stang MR, Ward HA, Hoeppner VH. The relationship between diabetes and tuberculosis in Saskatchewan: comparison of registered Indians and other Saskatchewan people. Can J Public Health. 2007; 98(1):55-9.

33. Watkins RE, Brennan R, Plant AJ. Tuberculin reactivity and the risk of tuberculosis: a review. Int J Tuberc Lung Dis. 2000;4:895–903.

34. Bowerman RJ. Tuberculin skin testing in BCG-vaccinated populations of adults and children at high risk for tuberculosis in Taiwan. Int J Tuberc Lung Dis. 2004;8(10):1228-33.

35. Menzies RI. Tuberculin skin testing. In: Reichman LB, Hershfield ES, editors. Tuberculosis: a comprehensive international approach, 2nd ed. New York: Marcel Dekker. 2000. p. 279–322.

Full Text

This work is licensed under a Creative Commons Attribution 4.0 International License.